ATP5I Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-ATP5I antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | ATP5I |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | immunogen affinity purified |
| Size | 0.03 mL, 0.1 mL, 0.2 mL |
| Concentration | 1 mg/ml |
| Applications | Western Blot (WB), Immunohistochemistry (IHC) Paraffin, ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Specificity: ATP5I Polyclonal Antibody detects endogenous levels of ATP5I protein. Mitochondrial ATP synthase catalyzes ATP synthesis, utilizing an electrochemical gradient of protons across the inner membrane during oxidative phosphorylation. It is composed of two linked multi-subunit complexes: the soluble catalytic core, F1, and the membrane-spanning component, Fo, which comprises the proton channel. The F1 complex consists of 5 different subunits (alpha, beta, gamma, delta, and epsilon) assembled in a ratio of 3 alpha, 3 beta, and a single representative of the other 3. The Fo seems to have nine subunits (a, b, c, d, e, f, g, F6 and 8). This gene encodes the e subunit of the Fo complex. Alternative splicing results in multiple transcrip |
| Immunogen | Immunogen: Synthesized peptide derived from the internal region of human ATP5I at AA range: 30-110 |
| Other Names | [Rabbit ATP5I; ATP5I; ATP5K; ATP synthase subunit e; mitochondrial; ATPase subunit e] |
| Gene, Accession # | [ATP5I], Gene ID: 521, NCBI: NP_009031.1, UniProt: P56385 |
| Catalog # | MBS9701461 |
| Price | $130, $220, $325 |
| Order / More Info | ATP5I Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies